SlateStone Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
11,720
+200
+2% +$17.5K 0.08% 158
2026
Q1
$982K Buy
11,520
+715
+7% +$63.7K 0.08% 161
2025
Q4
$854K Sell
10,805
-50
-0.5% -$3.92K 0.07% 176
2025
Q3
$868K Hold
10,855
0.08% 170
2025
Q2
$987K Hold
10,855
0.09% 156
2025
Q1
$1.02M Sell
10,855
-18
-0.2% -$1.61K 0.1% 145
2024
Q4
$988K Buy
10,873
+375
+4% +$35.8K 0.1% 150
2024
Q3
$1.09M Buy
10,498
+100
+1% +$10.2K 0.1% 148
2024
Q2
$1.01M Sell
10,398
-24
-0.2% -$2.21K 0.11% 146
2024
Q1
$939K Buy
10,422
+7,467
+253% +$633K 0.09% 151
2023
Q4
$236K Hold
2,955
0.03% 215
2023
Q3
$210K Buy
+2,955
New +$221K 0.03% 217
2020
Q3
Sell
-3,259
Closed -$239K 180
2020
Q2
$239K Buy
+3,259
New +$232K 0.05% 160

Other funds holding CL

SlateStone Wealth's CL Position: Q2 2026 in Review

SlateStone Wealth increased its Colgate-Palmolive (CL) stake by 1.7% in Q2 2026, buying an estimated $17.5K and bringing the position to 11,720 shares worth $1.07M. The position accounts for 0.08% of the portfolio, ranked #158.

SlateStone Wealth first reported a position in CL in Q2 2020 and has held it in 13 quarters since. The position peaked at $1.09M in Q3 2024. 623 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • SlateStone Wealth held 11,720 shares of Colgate-Palmolive worth $1.07M as of Q2 2026.
  • SlateStone Wealth bought 200 Colgate-Palmolive shares in Q2 2026, an estimated $17.5K.
  • Colgate-Palmolive made up 0.08% of SlateStone Wealth's portfolio in Q2 2026, its #158 holding.
  • SlateStone Wealth first reported a position in Colgate-Palmolive in Q2 2020 and has held it in 13 quarters since.
  • SlateStone Wealth's Colgate-Palmolive position peaked at $1.09M in Q3 2024.
  • 623 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.